The OnkPat Friday Seminar
This is a seminar series organized by the Department of Oncology-Pathology. The purpose of these seminars is to bring together researchers in cancer research to promote knowledge exchange and collaboration. Prominent national and international speakers are invited to share their latest research findings and insights in the field.
When? Usually on Fridays at 12:30 PM.
Where? Usually at BioClinicum, floor 3 (no special access required).
For whom? The seminar series is aimed at anyone who is interested in cancer research and who is a researcher, PhD student, medical student or physician.
Would you like to be added to the mailing list for invitations to upcoming Friday Seminars? Contact Erika Rindsjö.
Programme autumn 2026
September 4:
BioClinicum at 12:30, Translational development of theranostics, targeted radiopharmaceuticals for precision oncology, Thuy Tran, OnkPat, Karolinska Institutet
September 11:
BioClinicum at 12:30, Genetic approaches to understanding carcinoma metastasis, Christopher Lengner, University of Pennsylvania, USA
September 18:
BioClinicum at 12:30, Single cell epigenomics and developmental plasticity in acute myeloid leukemia: how different paths lead back to square one, Sander Lambo, Dana-Farber Cancer Institute, USA and OnkPat, Karolinska Institutet
September 25:
BioClinicum at 12:30, Quantitative Imaging of Nanomedicine Delivery in Cancer, Giovanni Marco Saladino, Stanford University, USA
October 2:
BioClinicum at 12:30, Cancer-associated fibroblasts modulate the immune response in the tumor microenvironment via a cross-talk with myeloid cells, Rudolf Oehler, Medical University Vienna, Austria
October 9:
Air&Fire, SciLifeLab Tomtebodavägen 23A, Solna at 14:00, Tracing early colorectal cancer risk factors through epigenetic fingerprints, Jose Antonio Seoane Fernández, Vall d'Hebron Institute of Oncology, Spain
October 16:
Marc Bygdeman, BioClinicum at 11:00, Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization, Yunfan Sun, Fudan University.
October 16:
Birger & Margareta Blombäck, BioClinicum at 12:30, Precision Therapy for Mesothelioma – seeking synthetic lethality, Dean Fennell, University Hospitals of Leicester, UK
October 22:
Marc Bygdeman, BioClinicum at 12:00, Decoding the Cellular Language of Cancer-From Spatial Multi-Omics and AI to Actionable Tumor Ecosystems, Linghua Wang, University of Texas MD Anderson Cancer Center.
October 23:
Kerstin Hagenfeldt, BioClinicum at 12:00, Physical properties of cells as a prediction of their fitness, Erdinc Sezgin, Karolinska Institutet, Department of Women's and Children's Health
November 13:
Kerstin Hagenfeldt, BioClinicum at 12:30, From cancer vaccines to adoptive T cell therapy: Advancing Immunotherapy strategies in solid cancer, Else Marit Inderberg, Oslo University Hospital
November 26:
Nanna Svartz, BioClinicum at 14:30, title TBA, Denarda Dangaj, Ludwig Institute for Cancer Research Lausanne
November 27:
Marc Bygdeman, BioClinicum at 12:30, title TBA, Samir El Andaloussi, Labmed, Karolinska Institutet
December 4:
Kerstin Hagenfeldt, BioClinicum at 12:00, Targeted drug delivery using engineered scaffold proteins for theranostics of cancer, Anzhelika Vorobyeva, Uppsala University
Programme spring 2027
January 15:
Birger & Margareta Blombäck, BioClinicum at 12:30, TBA
January 22:
Birger & Margareta Blombäck, BioClinicum at 12:30, TBA
January 29:
Marc Bygdeman, BioClinicum at 13:15, TBA
February 5:
Marc Bygdeman, BioClinicum at 12:30, TBA
February 12:
Marc Bygdeman, BioClinicum at 12:30, TBA
February 19:
Nanna Svartz, BioClinicum at 12:30, TBA
March 5:
Marc Bygdeman, BioClinicum at 12:30, TBA
March 12:
Nanna Svartz, BioClinicum at 12:30, TBA
April 2:
Birger & Margareta Blombäck, BioClinicum at 12:30, TBA
April 9:
Marc Bygdeman, BioClinicum at 12:30, TBA
May 14:
Kerstin Hagenfeldt, BioClinicum at 12:30, TBA
May 21:
Kerstin Hagenfeldt, BioClinicum at 12:30, TBA
June 4:
Kerstin Hagenfeldt, BioClinicum at 12:30, TBA
June 18:
Marc Bygdeman, BioClinicum at 12:30, TBA